These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11100024)

  • 1. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
    Hayag MV; Cohen JA; Kerdel FA
    J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoablative high-dose cyclophosphamide without stem cell rescue in pemphigus foliaceus.
    Cohen MA; Cohen JJ; Kerdel FA
    Int J Dermatol; 2002 Jun; 41(6):340-4. PubMed ID: 12100688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
    Nousari HC; Brodsky RA; Jones RJ; Grever MR; Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):750-4. PubMed ID: 10321604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
    Pandya AG; Sontheimer RD
    Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris.
    Nousari CH; Brodsky R; Anhalt GJ
    J Am Acad Dermatol; 2003 Jul; 49(1):148-50. PubMed ID: 12833031
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple autoimmune syndrome in a patient with pemphigus vulgaris: a new combination.
    Khaled A; Fazaa B; Mrabet N; Zeglaoui F; Kamoun MR
    Tunis Med; 2008 Jun; 86(6):595-7. PubMed ID: 19216455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus foliaceus presenting as eruptive seborrheic keratosis and responding to oral gold treatment.
    Bagheri MM; Alagheband M; Memar OM; Eiler DB
    J Drugs Dermatol; 2002 Dec; 1(3):333-4. PubMed ID: 12851996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
    Euler HH; Löffler H; Christophers E
    Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus vulgaris in association with silicosis.
    Haustein UF
    Eur J Dermatol; 2000 Dec; 10(8):614-6. PubMed ID: 11125324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Arin MJ; Engert A; Krieg T; Hunzelmann N
    Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment of corticoid-resistant pemphigus with high-dose intravenous immunoglobulins].
    Sibaud V; Beylot-Barry M; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2000 Apr; 127(4):408-10. PubMed ID: 10844264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.
    Turner MS; Sutton D; Sauder DN
    J Am Acad Dermatol; 2000 Dec; 43(6):1058-64. PubMed ID: 11100023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
    Lever WF; Schaumburg-Lever G
    Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemphigus vulgaris localized to the nose and cheeks.
    Baykal C; Azizlerli G; Thoma-Uszynski S; Hertl M
    J Am Acad Dermatol; 2002 Dec; 47(6):875-80. PubMed ID: 12451372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged treatment with rituximab in patients with refractory pemphigus vulgaris.
    Barrera MV; Mendiola MV; Bosch RJ; Herrera E
    J Dermatolog Treat; 2007; 18(5):312-4. PubMed ID: 17852643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.